Chromatography, High Pressure Liquid
Chromatography, Affinity
Chromatography, Gel
Chromatography
Chromatography, Ion Exchange
Chromatography, Gas
Chromatography, Thin Layer
Chromatography, DEAE-Cellulose
Electrophoresis, Polyacrylamide Gel
Chromatography, Agarose
Chromatography, Paper
Mass Spectrometry
Molecular Sequence Data
Gas Chromatography-Mass Spectrometry
Amino Acid Sequence
Chromatography, Reverse-Phase
Amino Acids
Hydrogen-Ion Concentration
Substrate Specificity
Spectrophotometry, Ultraviolet
Cattle
Chemistry
Chemical Phenomena
Tandem Mass Spectrometry
Carbohydrates
Spectrometry, Mass, Electrospray Ionization
Isoelectric Focusing
Escherichia coli
Countercurrent Distribution
Chromatography, Micellar Electrokinetic Capillary
Chemical Fractionation
Carbohydrate Sequence
Reproducibility of Results
Oligosaccharides
Peptide Fragments
Isoelectric Point
Magnetic Resonance Spectroscopy
Rabbits
Liver
Temperature
Protein Binding
Trypsin
Macromolecular Substances
Solubility
Base Sequence
Indicators and Reagents
Calibration
Immunodiffusion
Peptides
Reference Standards
Hydroxyapatites
Glycoproteins
Cloning, Molecular
Binding Sites
Radioimmunoassay
Microchemistry
Biological Assay
Fatty Acids
Molecular Structure
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Stereoisomerism
Scavenger Receptors, Class D
Species Specificity
Electrophoresis, Paper
Chemistry Techniques, Analytical
Swine
Chemical Precipitation
Limit of Detection
Lectins
Isoenzymes
Plant Extracts
Proteins
Sequence Homology, Amino Acid
Solvents
Solid Phase Extraction
Centrifugation, Density Gradient
Brain Chemistry
Anion Exchange Resins
Methanol
Carrier Proteins
Rats, Inbred Strains
Glycopeptides
Electrophoresis
Peptide Mapping
Oxidation-Reduction
Phospholipids
Flame Ionization
Glycolipids
Spectrophotometry
Algorithms
Ultracentrifugation
Isomerism
Spectrometry, Mass, Fast Atom Bombardment
Enzyme Stability
DNA
Physicochemical Phenomena
Chemistry, Physical
Chromatography, Supercritical Fluid
Durapatite
Biotransformation
Cell Membrane
Detergents
Protein Conformation
Sensitivity and Specificity
Glycosylation
Cyanogen Bromide
Plants
Glycosides
Immunoelectrophoresis
Blood Proteins
Cytosol
Cells, Cultured
Monosaccharides
Endopeptidases
Brain
Chymotrypsin
Erythrocytes
Electrophoresis, Disc
Blotting, Western
Culture Media
Mutation
Chickens
Binding, Competitive
Mannose
Structure-Activity Relationship
Quality Control
Isotope Labeling
Galactose
Circular Dichroism
Methylation
Microsomes, Liver
Fermentation
Tissue Distribution
Immune Sera
Trifluoroacetic Acid
Ultrafiltration
Peptide Hydrolases
Electrochemistry
Plants, Medicinal
Pesticide Residues
Sequence Alignment
Plant Lectins
Cross Reactions
Adsorption
Carbon Radioisotopes
Streptomyces
Immunoassay
Sialic Acids
Protease Inhibitors
Edetic Acid
Acetates
Sequence Analysis
Antibodies
Models, Biological
Cations, Divalent
Immunosorbent Techniques
Membrane Proteins
Pharmaceutical Preparations
Sugar Alcohols
Lipids
Silicon Dioxide
Kidney
Heparin
Recombinant Fusion Proteins
Gangliosides
Enzyme-Linked Immunosorbent Assay
Cellulose
Spectrum Analysis
Drug Contamination
Electrophoresis, Gel, Two-Dimensional
Seeds
Glycosaminoglycans
Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4. (1/1431)
Platelet factor 4 (PF-4) is a platelet-derived alpha-chemokine that binds to and activates human neutrophils to undergo specific functions like exocytosis or adhesion. PF-4 binding has been shown to be independent of interleukin-8 receptors and could be inhibited by soluble chondroitin sulfate type glycosaminoglycans or by pretreatment of cells with chondroitinase ABC. Here we present evidence that surface-expressed neutrophil glycosaminoglycans are of chondroitin sulfate type and that this species binds to the tetrameric form of PF-4. The glycosaminoglycans consist of a single type of chain with an average molecular mass of approximately 23 kDa and are composed of approximately 85-90% chondroitin 4-sulfate disaccharide units type CSA (-->4GlcAbeta1-->3GalNAc(4-O-sulfate)beta1-->) and of approximately 10-15% di-O-sulfated disaccharide units. A major part of these di-O-sulfated disaccharide units are CSE units (-->4GlcAbeta1-->3GalNAc(4,6-O-sulfate)beta1-->). Binding studies revealed that the interaction of chondroitin sulfate with PF-4 required at least 20 monosaccharide units for significant binding. The di-O-sulfated disaccharide units in neutrophil glycosaminoglycans clearly promoted the affinity to PF-4, which showed a Kd approximately 0.8 microM, as the affinities of bovine cartilage chondroitin sulfate A, porcine skin dermatan sulfate, or bovine cartilage chondroitin sulfate C, all consisting exclusively of monosulfated disaccharide units, were found to be 3-5-fold lower. Taken together, our data indicate that chondroitin sulfate chains function as physiologically relevant binding sites for PF-4 on neutrophils and that the affinity of these chains for PF-4 is controlled by their degree of sulfation. (+info)Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. (2/1431)
A natural low molecular weight heparin (8.5 kDa), with an anticoagulant activity of 95 IU/mg by the USP assay, was isolated from the shrimp Penaeus brasiliensis. The crustacean heparin was susceptible to both heparinase and heparitinase II from Flavobacterium heparinum forming tri- and di-sulfated disaccharides as the mammalian heparins. (13)C and (1)H NMR spectroscopy revealed that the shrimp heparin was enriched in both glucuronic and non-sulfated iduronic acid residues. The in vitro anticlotting activities in different steps of the coagulation cascade have shown that its anticoagulant action is mainly exerted through the inhibition of factor Xa and heparin cofactor II-mediated inhibition of thrombin. The shrimp heparin has also a potent in vivo antithrombotic activity comparable to the mammalian low molecular weight heparins. (+info)Stereochemical course and steady state mechanism of the reaction catalyzed by the GDP-fucose synthetase from Escherichia coli. (3/1431)
Recently the genes encoding the human and Escherichia coli GDP-mannose dehydratase and GDP-fucose synthetase (GFS) protein have been cloned and it has been shown that these two proteins alone are sufficient to convert GDP mannose to GDP fucose in vitro. GDP-fucose synthetase from E. coli is a novel dual function enzyme in that it catalyzes epimerizations and a reduction reaction at the same active site. This aspect separates fucose biosynthesis from that of other deoxy and dideoxy sugars in which the epimerase and reductase activities are present on separate enzymes encoded by separate genes. By NMR spectroscopy we have shown that GFS catalyzes the stereospecific hydride transfer of the ProS hydrogen from NADPH to carbon 4 of the mannose sugar. This is consistent with the stereospecificity observed for other members of the short chain dehydrogenase reductase family of enzymes of which GFS is a member. Additionally the enzyme is able to catalyze the epimerization reaction in the absence of NADP or NADPH. The kinetic mechanism of GFS as determined by product inhibition and fluorescence binding studies is consistent with a random mechanism. The dissociation constants determined from fluorescence studies indicate that the enzyme displays a 40-fold stronger affinity for the substrate NADPH as compared with the product NADP and utilizes NADPH preferentially as compared with NADH. This study on GFS, a unique member of the short chain dehydrogenase reductase family, coupled with that of its recently published crystal structure should aid in the development of antimicrobial or anti-inflammatory compounds that act by blocking selectin-mediated cell adhesion. (+info)Sensitive assay for mitochondrial DNA polymerase gamma. (4/1431)
BACKGROUND: The mitochondrial DNA polymerase gamma is the principal polymerase required for mitochondrial DNA replication. Primary or secondary deficiencies in the activity of DNA polymerase gamma may lead to mitochondrial DNA depletion. We describe a sensitive and robust clinical assay for this enzyme. METHODS: The assay was performed on mitochondria isolated from skeletal muscle biopsies. High-molecular weight polynucleotide reaction products were captured on ion-exchange paper, examined qualitatively by autoradiography, and quantified by scintillation counting. RESULTS: Kinetic analysis of DNA polymerase gamma by this method showed a K(m) for dTTP of 1.43 micromol/L and a K(i) for azidothymidine triphosphate of 0.861 micromol/L. The assay was linear from 0.1 to 2 microgram of mitochondrial protein. The detection limit was 30 units (30 fmol dTMP incorporated in 30 min). The linear dynamic range was three orders of magnitude; 30-30 000 units. Imprecision (CV) was 6.4% within day and 12% between days. Application of this assay to a mixed population of 38 patients referred for evaluation of mitochondrial disease revealed a distribution with a range of 0-2506 U/microgram, reflecting extensive biologic variation among patients with neuromuscular disease. CONCLUSION: This assay provides a useful adjunct to current laboratory methods for the evaluation of patients with suspected mitochondrial DNA depletion syndromes. (+info)Localization of the IgG effector site for monocyte receptors. (5/1431)
A peptide consisting of 10 amino acids derived from the CH3 region of human IgG was shown to bind to monocytes and to inhibit rosette formation of antibody-coated erythrocytes with human monocytes. Two myeloma proteins of the IgG1 and IgG3 subclass, both with known deletions in the CH2 region of the gamma chain, showed unimpaired ability to bind to monocytes. These experiments suggest that the isolated peptide represents the primary site of attachment of IgG to monocytes. (+info)In yeast the export of small glycopeptides from the endoplasmic reticulum into the cytosol is not affected by the structure of their oligosaccharide chains. (6/1431)
A "quality control" system associated with the endoplasmic reticulum (ER) that discriminates between misfolded proteins and correctly folded proteins is present in a variety of eukaryotic cells, including yeast. Recently, it has been shown that misfolded proteins that are N -glycosylated in the lumen of the ER are transported out of the ER, de-N-glycosylated by a soluble peptide: N -glycanase (PNGase) and degraded by action of the proteasome. It also has been shown that small N -glycosylatable peptides follow a fate similar to that of misfolded proteins, i.e., glycosylation in the lumen of the ER, transport out of the ER, and de- N -glycosylation in the cytosol. These processes of retrograde glycopeptide transport and de- N -glycosylation have been observed in mammalian cells, as well as in yeast cells. However, little is known about the mechanism involved in the movement of glycopeptides from the ER to the cytosol. Here we report a simple method for assaying N -glycosylation/de- N -glycosylation by simple paper chromatographic and electrophoretic techniques using an N -glycosylatable(3)H-labeled tripeptide as a substrate. With this method, we confirmed the cytosolic localization of the de- N -glycosylated peptide, which supports the idea that de- N -glycosylation occurs after the export of the glycopeptide from the lumen of the ER to the cytosol. Further, we found that the variations in the structure of the oligosaccharide chain on the glycopeptide did not cause differences in the export of the glycopeptide. This finding suggests that the mechanism for the export of small glycopeptides may differ from that of misfolded (glyco)proteins. (+info)Elaboration of pyrimidine-specific nucleosidases by human lymphoblastoid cells of established cultures. (7/1431)
Pyrimidine-specific nucleosidases were released rapidly by human lymphoblastoid cells of established cultures when incubated under certain culture conditions having no adverse affect on their viability or morphology. Nucleosidase production was not restricted to any particular type of lymphoblastoid line; enzymes with a high level of activity were elaborated by cells of cultures initiated from healthy subjects and patients with uncontrolled lymphocytic or myelocytic leukemia, as well as by cells of cultures exhibiting mostly B- or T-cell properties. Tritiated thymine and uracil, which were not incorporated to any appreciable extent by DNA- and RNA-synthesizing cells, were identified by paper chromatography as the primary products arising from nucleosidase degradation of radiolabeled thymidine, uridine, and cytidine. Neither adenosine nor guanosine was catabolized. These heat-labile and ultraviolet-sensitive enzymes with a molecular weight of 5 to 10 X 10(4) did not affect the viability, morphology, or proliferation of lymphocytes in mitogenactivated cultures, lymphoblastoid cells in long-term cultures, or fibroblasts in monolayer cultures. (+info)Covalent linkage of polyamines to peptidoglycan in Anaerovibrio lipolytica. (8/1431)
Spermidine and cadaverine were found to be constituents of the cell wall peptidoglycan of Anaerovibrio lipolytica, a strictly anaerobic bacterium. The peptidoglycan was degraded with the N-acetylmuramyl-L-alanine amidase and endopeptidase into two peptide fragments, peptide I and peptide II, at a molar ratio of 4:1. Peptides I and II were identified as L-alanine-D-glutamic acid(alphacadaverine)gammameso-diaminopimelic acid (DAP)-D-alanine and L-alanine-D-glutamic acid(alphaspermidine)gammameso-DAP-D-alanine, respectively. The N(1)-amino group of spermidine was linked to the alpha-carboxyl group of the D-glutamic acid residue of peptide II. (+info)The condition typically affects children and young adults, and its symptoms can vary in severity. The most common symptoms include:
* Swelling of the eyelids and face
* Pain and tenderness in the affected eye
* Difficulty moving the eyes
* Double vision or loss of vision in the affected eye
* Headaches
* Fever
Tolosa-Hunt syndrome is caused by an inflammation of the adenoids, which are gland-like tissues located near the nasal passages. The condition can be triggered by a viral or bacterial infection, allergies, or other factors that cause inflammation.
Diagnosis of Tolosa-Hunt syndrome is based on a combination of physical examination, medical history, and imaging tests such as CT scans or MRI. Treatment typically involves antibiotics for bacterial infections, anti-inflammatory medications, and drainage of any abscesses that may have formed. In severe cases, surgery may be necessary to relieve pressure on the affected eye.
Tolosa-Hunt syndrome is a rare condition, but it can be challenging to diagnose and treat. It is essential to seek medical attention if you or your child experiences symptoms of this condition, as early treatment can help prevent long-term complications and improve outcomes.
Neoplasm refers to an abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous). Neoplasms can occur in any part of the body and can affect various organs and tissues. The term "neoplasm" is often used interchangeably with "tumor," but while all tumors are neoplasms, not all neoplasms are tumors.
Types of Neoplasms
There are many different types of neoplasms, including:
1. Carcinomas: These are malignant tumors that arise in the epithelial cells lining organs and glands. Examples include breast cancer, lung cancer, and colon cancer.
2. Sarcomas: These are malignant tumors that arise in connective tissue, such as bone, cartilage, and fat. Examples include osteosarcoma (bone cancer) and soft tissue sarcoma.
3. Lymphomas: These are cancers of the immune system, specifically affecting the lymph nodes and other lymphoid tissues. Examples include Hodgkin lymphoma and non-Hodgkin lymphoma.
4. Leukemias: These are cancers of the blood and bone marrow that affect the white blood cells. Examples include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
5. Melanomas: These are malignant tumors that arise in the pigment-producing cells called melanocytes. Examples include skin melanoma and eye melanoma.
Causes and Risk Factors of Neoplasms
The exact causes of neoplasms are not fully understood, but there are several known risk factors that can increase the likelihood of developing a neoplasm. These include:
1. Genetic predisposition: Some people may be born with genetic mutations that increase their risk of developing certain types of neoplasms.
2. Environmental factors: Exposure to certain environmental toxins, such as radiation and certain chemicals, can increase the risk of developing a neoplasm.
3. Infection: Some neoplasms are caused by viruses or bacteria. For example, human papillomavirus (HPV) is a common cause of cervical cancer.
4. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and a poor diet can increase the risk of developing certain types of neoplasms.
5. Family history: A person's risk of developing a neoplasm may be higher if they have a family history of the condition.
Signs and Symptoms of Neoplasms
The signs and symptoms of neoplasms can vary depending on the type of cancer and where it is located in the body. Some common signs and symptoms include:
1. Unusual lumps or swelling
2. Pain
3. Fatigue
4. Weight loss
5. Change in bowel or bladder habits
6. Unexplained bleeding
7. Coughing up blood
8. Hoarseness or a persistent cough
9. Changes in appetite or digestion
10. Skin changes, such as a new mole or a change in the size or color of an existing mole.
Diagnosis and Treatment of Neoplasms
The diagnosis of a neoplasm usually involves a combination of physical examination, imaging tests (such as X-rays, CT scans, or MRI scans), and biopsy. A biopsy involves removing a small sample of tissue from the suspected tumor and examining it under a microscope for cancer cells.
The treatment of neoplasms depends on the type, size, location, and stage of the cancer, as well as the patient's overall health. Some common treatments include:
1. Surgery: Removing the tumor and surrounding tissue can be an effective way to treat many types of cancer.
2. Chemotherapy: Using drugs to kill cancer cells can be effective for some types of cancer, especially if the cancer has spread to other parts of the body.
3. Radiation therapy: Using high-energy radiation to kill cancer cells can be effective for some types of cancer, especially if the cancer is located in a specific area of the body.
4. Immunotherapy: Boosting the body's immune system to fight cancer can be an effective treatment for some types of cancer.
5. Targeted therapy: Using drugs or other substances to target specific molecules on cancer cells can be an effective treatment for some types of cancer.
Prevention of Neoplasms
While it is not always possible to prevent neoplasms, there are several steps that can reduce the risk of developing cancer. These include:
1. Avoiding exposure to known carcinogens (such as tobacco smoke and radiation)
2. Maintaining a healthy diet and lifestyle
3. Getting regular exercise
4. Not smoking or using tobacco products
5. Limiting alcohol consumption
6. Getting vaccinated against certain viruses that are associated with cancer (such as human papillomavirus, or HPV)
7. Participating in screening programs for early detection of cancer (such as mammograms for breast cancer and colonoscopies for colon cancer)
8. Avoiding excessive exposure to sunlight and using protective measures such as sunscreen and hats to prevent skin cancer.
It's important to note that not all cancers can be prevented, and some may be caused by factors that are not yet understood or cannot be controlled. However, by taking these steps, individuals can reduce their risk of developing cancer and improve their overall health and well-being.
There are two main types of hemolysis:
1. Intravascular hemolysis: This type occurs within the blood vessels and is caused by factors such as mechanical injury, oxidative stress, and certain infections.
2. Extravascular hemolysis: This type occurs outside the blood vessels and is caused by factors such as bone marrow disorders, splenic rupture, and certain medications.
Hemolytic anemia is a condition that occurs when there is excessive hemolysis of RBCs, leading to a decrease in the number of healthy red blood cells in the body. This can cause symptoms such as fatigue, weakness, pale skin, and shortness of breath.
Some common causes of hemolysis include:
1. Genetic disorders such as sickle cell anemia and thalassemia.
2. Autoimmune disorders such as autoimmune hemolytic anemia (AIHA).
3. Infections such as malaria, babesiosis, and toxoplasmosis.
4. Medications such as antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and blood thinners.
5. Bone marrow disorders such as aplastic anemia and myelofibrosis.
6. Splenic rupture or surgical removal of the spleen.
7. Mechanical injury to the blood vessels.
Diagnosis of hemolysis is based on a combination of physical examination, medical history, and laboratory tests such as complete blood count (CBC), blood smear examination, and direct Coombs test. Treatment depends on the underlying cause and may include supportive care, blood transfusions, and medications to suppress the immune system or prevent infection.
Examples of experimental liver neoplasms include:
1. Hepatocellular carcinoma (HCC): This is the most common type of primary liver cancer and can be induced experimentally by injecting carcinogens such as diethylnitrosamine (DEN) or dimethylbenz(a)anthracene (DMBA) into the liver tissue of animals.
2. Cholangiocarcinoma: This type of cancer originates in the bile ducts within the liver and can be induced experimentally by injecting chemical carcinogens such as DEN or DMBA into the bile ducts of animals.
3. Hepatoblastoma: This is a rare type of liver cancer that primarily affects children and can be induced experimentally by administering chemotherapy drugs to newborn mice or rats.
4. Metastatic tumors: These are tumors that originate in other parts of the body and spread to the liver through the bloodstream or lymphatic system. Experimental models of metastatic tumors can be studied by injecting cancer cells into the liver tissue of animals.
The study of experimental liver neoplasms is important for understanding the underlying mechanisms of liver cancer development and progression, as well as identifying potential therapeutic targets for the treatment of this disease. Animal models can be used to test the efficacy of new drugs or therapies before they are tested in humans, which can help to accelerate the development of new treatments for liver cancer.
The symptoms of hemorrhagic shock may include:
* Pale, cool, or clammy skin
* Fast heart rate
* Shallow breathing
* Confusion or loss of consciousness
* Decreased urine output
Treatment of hemorrhagic shock typically involves replacing lost blood volume with IV fluids and/or blood transfusions. In severe cases, medications such as vasopressors may be used to raise blood pressure and improve circulation. Surgical intervention may also be necessary to control the bleeding source.
The goal of treatment is to restore blood flow and oxygenation to vital organs, such as the brain, heart, and kidneys, and to prevent further bleeding and hypovolemia. Early recognition and aggressive treatment of hemorrhagic shock are critical to preventing severe complications and mortality.
The signs and symptoms of CE can vary depending on the location of the tumor, but they may include:
* Lumps or swelling in the neck, underarm, or groin area
* Fever
* Fatigue
* Weight loss
* Night sweats
* Swollen lymph nodes
* Pain in the affected area
CE is caused by a genetic mutation that leads to uncontrolled cell growth and division. The exact cause of the mutation is not fully understood, but it is believed to be linked to exposure to certain viruses or chemicals.
Diagnosis of CE typically involves a combination of physical examination, imaging tests such as CT scans or PET scans, and biopsy to confirm the presence of cancer cells. Treatment options for CE depend on the stage and location of the tumor, but may include:
* Chemotherapy to kill cancer cells
* Radiation therapy to shrink the tumor
* Surgery to remove the tumor
* Immunotherapy to boost the immune system's ability to fight the cancer
Overall, CE is a rare and aggressive form of cancer that requires prompt diagnosis and treatment to improve outcomes.
Types of experimental neoplasms include:
* Xenografts: tumors that are transplanted into animals from another species, often humans.
* Transgenic tumors: tumors that are created by introducing cancer-causing genes into an animal's genome.
* Chemically-induced tumors: tumors that are caused by exposure to certain chemicals or drugs.
The use of experimental neoplasms in research has led to significant advances in our understanding of cancer biology and the development of new treatments for the disease. However, the use of animals in cancer research is a controversial topic and alternatives to animal models are being developed and implemented.
Examples of inborn errors of carbohydrate metabolism include:
1. Phosphofructokinase (PFK) deficiency: This is a rare genetic disorder that affects the body's ability to break down glucose-6-phosphate, a type of sugar. Symptoms can include seizures, developmental delays, and metabolic acidosis.
2. Galactosemia: This is a group of genetic disorders that affect the body's ability to process galactose, a type of sugar found in milk and other dairy products. Untreated, galactosemia can lead to serious health problems, including liver disease, kidney damage, and cognitive impairment.
3. Glycogen storage disease type II (GSDII): This is a rare genetic disorder that affects the body's ability to store and use glycogen, a complex carbohydrate found in the liver and muscles. Symptoms can include low blood sugar, fatigue, and muscle weakness.
4. Pompe disease: This is a rare genetic disorder that affects the body's ability to break down glycogen. Symptoms can include muscle weakness, breathing problems, and heart problems.
5. Mucopolysaccharidoses (MPS): These are a group of genetic disorders that affect the body's ability to break down sugar molecules. Symptoms can include joint stiffness, developmental delays, and heart problems.
Inborn errors of carbohydrate metabolism can be diagnosed through blood tests, urine tests, and other diagnostic procedures. Treatment depends on the specific disorder and may involve a combination of dietary changes, medication, and other therapies.
The most common types of hemoglobinopathies include:
1. Sickle cell disease: This is caused by a point mutation in the HBB gene that codes for the beta-globin subunit of hemoglobin. It results in the production of sickle-shaped red blood cells, which can cause anemia, infections, and other complications.
2. Thalassemia: This is a group of genetic disorders that affect the production of hemoglobin and can result in anemia, fatigue, and other complications.
3. Hemophilia A: This is caused by a defect in the F8 gene that codes for coagulation factor VIII, which is essential for blood clotting. It can cause bleeding episodes, especially in males.
4. Glucose-6-phosphate dehydrogenase (G6PD) deficiency: This is caused by a point mutation in the G6PD gene that codes for an enzyme involved in red blood cell production. It can cause hemolytic anemia, especially in individuals who consume certain foods or medications.
5. Hereditary spherocytosis: This is caused by point mutations in the ANK1 or SPTA1 genes that code for proteins involved in red blood cell membrane structure. It can cause hemolytic anemia and other complications.
Hemoglobinopathies can be diagnosed through genetic testing, such as DNA sequencing or molecular genetic analysis. Treatment options vary depending on the specific disorder but may include blood transfusions, medications, and in some cases, bone marrow transplantation.
There are different types of Breast Neoplasms such as:
1. Fibroadenomas: These are benign tumors that are made up of glandular and fibrous tissues. They are usually small and round, with a smooth surface, and can be moved easily under the skin.
2. Cysts: These are fluid-filled sacs that can develop in both breast tissue and milk ducts. They are usually benign and can disappear on their own or be drained surgically.
3. Ductal Carcinoma In Situ (DCIS): This is a precancerous condition where abnormal cells grow inside the milk ducts. If left untreated, it can progress to invasive breast cancer.
4. Invasive Ductal Carcinoma (IDC): This is the most common type of breast cancer and starts in the milk ducts but grows out of them and invades surrounding tissue.
5. Invasive Lobular Carcinoma (ILC): It originates in the milk-producing glands (lobules) and grows out of them, invading nearby tissue.
Breast Neoplasms can cause various symptoms such as a lump or thickening in the breast or underarm area, skin changes like redness or dimpling, change in size or shape of one or both breasts, discharge from the nipple, and changes in the texture or color of the skin.
Treatment options for Breast Neoplasms may include surgery such as lumpectomy, mastectomy, or breast-conserving surgery, radiation therapy which uses high-energy beams to kill cancer cells, chemotherapy using drugs to kill cancer cells, targeted therapy which uses drugs or other substances to identify and attack cancer cells while minimizing harm to normal cells, hormone therapy, immunotherapy, and clinical trials.
It is important to note that not all Breast Neoplasms are cancerous; some are benign (non-cancerous) tumors that do not spread or grow.
There are several types of poisoning, including:
1. Acute poisoning: This occurs when a person is exposed to a large amount of a poisonous substance over a short period of time. Symptoms can include nausea, vomiting, diarrhea, and difficulty breathing.
2. Chronic poisoning: This occurs when a person is exposed to a small amount of a poisonous substance over a longer period of time. Symptoms can include fatigue, weight loss, and damage to organs such as the liver or kidneys.
3. Occupational poisoning: This occurs when a worker is exposed to a poisonous substance in the course of their work. Examples include exposure to pesticides, lead, and mercury.
4. Environmental poisoning: This occurs when a person is exposed to a poisonous substance in their environment, such as through contaminated water or soil.
5. Food poisoning: This occurs when a person eats food that has been contaminated with a poisonous substance, such as bacteria or viruses. Symptoms can include nausea, vomiting, diarrhea, and stomach cramps.
Treatment for poisoning depends on the type of poison and the severity of the exposure. Some common treatments include activated charcoal to absorb the poison, medications to counteract the effects of the poison, and supportive care such as fluids and oxygen. In severe cases, hospitalization may be necessary.
Prevention is key in avoiding poisoning. This includes proper storage and disposal of household chemicals, using protective gear when working with hazardous substances, and avoiding exposure to known poisons such as certain plants and animals. Education and awareness are also important in preventing poisoning, such as understanding the symptoms of poisoning and seeking medical attention immediately if suspected.
Liver neoplasms, also known as liver tumors or hepatic tumors, are abnormal growths of tissue in the liver. These growths can be benign (non-cancerous) or malignant (cancerous). Malignant liver tumors can be primary, meaning they originate in the liver, or metastatic, meaning they spread to the liver from another part of the body.
There are several types of liver neoplasms, including:
1. Hepatocellular carcinoma (HCC): This is the most common type of primary liver cancer and arises from the main cells of the liver (hepatocytes). HCC is often associated with cirrhosis and can be caused by viral hepatitis or alcohol abuse.
2. Cholangiocarcinoma: This type of cancer arises from the cells lining the bile ducts within the liver (cholangiocytes). Cholangiocarcinoma is rare and often diagnosed at an advanced stage.
3. Hemangiosarcoma: This is a rare type of cancer that originates in the blood vessels of the liver. It is most commonly seen in dogs but can also occur in humans.
4. Fibromas: These are benign tumors that arise from the connective tissue of the liver (fibrocytes). Fibromas are usually small and do not spread to other parts of the body.
5. Adenomas: These are benign tumors that arise from the glandular cells of the liver (hepatocytes). Adenomas are usually small and do not spread to other parts of the body.
The symptoms of liver neoplasms vary depending on their size, location, and whether they are benign or malignant. Common symptoms include abdominal pain, fatigue, weight loss, and jaundice (yellowing of the skin and eyes). Diagnosis is typically made through a combination of imaging tests such as CT scans, MRI scans, and ultrasound, and a biopsy to confirm the presence of cancer cells.
Treatment options for liver neoplasms depend on the type, size, location, and stage of the tumor, as well as the patient's overall health. Surgery may be an option for some patients with small, localized tumors, while others may require chemotherapy or radiation therapy to shrink the tumor before surgery can be performed. In some cases, liver transplantation may be necessary.
Prognosis for liver neoplasms varies depending on the type and stage of the cancer. In general, early detection and treatment improve the prognosis, while advanced-stage disease is associated with a poorer prognosis.
1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.
2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.
3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.
4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.
5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.
6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.
7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.
8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.
9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.
10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.
There are several risk factors for developing HCC, including:
* Cirrhosis, which can be caused by heavy alcohol consumption, viral hepatitis (such as hepatitis B and C), or fatty liver disease
* Family history of liver disease
* Chronic obstructive pulmonary disease (COPD)
* Diabetes
* Obesity
HCC can be challenging to diagnose, as the symptoms are non-specific and can be similar to those of other conditions. However, some common symptoms of HCC include:
* Yellowing of the skin and eyes (jaundice)
* Fatigue
* Loss of appetite
* Abdominal pain or discomfort
* Weight loss
If HCC is suspected, a doctor may perform several tests to confirm the diagnosis, including:
* Imaging tests, such as ultrasound, CT scan, or MRI, to look for tumors in the liver
* Blood tests to check for liver function and detect certain substances that are produced by the liver
* Biopsy, which involves removing a small sample of tissue from the liver to examine under a microscope
Once HCC is diagnosed, treatment options will depend on several factors, including the stage and location of the cancer, the patient's overall health, and their personal preferences. Treatment options may include:
* Surgery to remove the tumor or parts of the liver
* Ablation, which involves destroying the cancer cells using heat or cold
* Chemoembolization, which involves injecting chemotherapy drugs into the hepatic artery to reach the cancer cells
* Targeted therapy, which uses drugs or other substances to target specific molecules that are involved in the growth and spread of the cancer
Overall, the prognosis for HCC is poor, with a 5-year survival rate of approximately 20%. However, early detection and treatment can improve outcomes. It is important for individuals at high risk for HCC to be monitored regularly by a healthcare provider, and to seek medical attention if they experience any symptoms.
Examples of inborn errors of metabolism include:
1. Phenylketonuria (PKU): A disorder that affects the body's ability to break down the amino acid phenylalanine, leading to a buildup of this substance in the blood and brain.
2. Hypothyroidism: A condition in which the thyroid gland does not produce enough thyroid hormones, leading to developmental delays, intellectual disability, and other health problems.
3. Maple syrup urine disease (MSUD): A disorder that affects the body's ability to break down certain amino acids, leading to a buildup of these substances in the blood and urine.
4. Glycogen storage diseases: A group of disorders that affect the body's ability to store and use glycogen, a form of carbohydrate energy.
5. Mucopolysaccharidoses (MPS): A group of disorders that affect the body's ability to produce and break down certain sugars, leading to a buildup of these substances in the body.
6. Citrullinemia: A disorder that affects the body's ability to break down the amino acid citrulline, leading to a buildup of this substance in the blood and urine.
7. Homocystinuria: A disorder that affects the body's ability to break down certain amino acids, leading to a buildup of these substances in the blood and urine.
8. Tyrosinemia: A disorder that affects the body's ability to break down the amino acid tyrosine, leading to a buildup of this substance in the blood and liver.
Inborn errors of metabolism can be diagnosed through a combination of physical examination, medical history, and laboratory tests such as blood and urine tests. Treatment for these disorders varies depending on the specific condition and may include dietary changes, medication, and other therapies. Early detection and treatment can help manage symptoms and prevent complications.
Treatment for uremia typically involves dialysis or kidney transplantation to remove excess urea from the blood and restore normal kidney function. In some cases, medications may be prescribed to help manage symptoms such as high blood pressure, anemia, or electrolyte imbalances.
The term "uremia" is derived from the Greek words "oura," meaning "urea," and "emia," meaning "in the blood." It was first used in the medical literature in the late 19th century to describe a condition caused by excess urea in the blood. Today, it remains an important diagnostic term in nephrology and is often used interchangeably with the term "uremic syndrome."
There are several types of lung neoplasms, including:
1. Adenocarcinoma: This is the most common type of lung cancer, accounting for approximately 40% of all lung cancers. It is a malignant tumor that originates in the glands of the respiratory tract and can be found in any part of the lung.
2. Squamous cell carcinoma: This type of lung cancer accounts for approximately 25% of all lung cancers and is more common in men than women. It is a malignant tumor that originates in the squamous cells lining the airways of the lungs.
3. Small cell lung cancer (SCLC): This is a highly aggressive form of lung cancer that accounts for approximately 15% of all lung cancers. It is often found in the central parts of the lungs and can spread quickly to other parts of the body.
4. Large cell carcinoma: This is a rare type of lung cancer that accounts for only about 5% of all lung cancers. It is a malignant tumor that originates in the large cells of the respiratory tract and can be found in any part of the lung.
5. Bronchioalveolar carcinoma (BAC): This is a rare type of lung cancer that originates in the cells lining the airways and alveoli of the lungs. It is more common in women than men and tends to affect older individuals.
6. Lymphangioleiomyomatosis (LAM): This is a rare, progressive, and often fatal lung disease that primarily affects women of childbearing age. It is characterized by the growth of smooth muscle-like cells in the lungs and can lead to cysts, lung collapse, and respiratory failure.
7. Hamartoma: This is a benign tumor that originates in the tissue of the lungs and is usually found in children. It is characterized by an overgrowth of normal lung tissue and can be treated with surgery.
8. Secondary lung cancer: This type of cancer occurs when cancer cells from another part of the body spread to the lungs through the bloodstream or lymphatic system. It is more common in people who have a history of smoking or exposure to other carcinogens.
9. Metastatic cancer: This type of cancer occurs when cancer cells from another part of the body spread to the lungs through the bloodstream or lymphatic system. It is more common in people who have a history of smoking or exposure to other carcinogens.
10. Mesothelioma: This is a rare and aggressive form of cancer that originates in the lining of the lungs or abdomen. It is caused by asbestos exposure and can be treated with surgery, chemotherapy, and radiation therapy.
Lung diseases can also be classified based on their cause, such as:
1. Infectious diseases: These are caused by bacteria, viruses, or other microorganisms and can include pneumonia, tuberculosis, and bronchitis.
2. Autoimmune diseases: These are caused by an overactive immune system and can include conditions such as sarcoidosis and idiopathic pulmonary fibrosis.
3. Genetic diseases: These are caused by inherited mutations in genes that affect the lungs and can include cystic fibrosis and primary ciliary dyskinesia.
4. Environmental diseases: These are caused by exposure to harmful substances such as tobacco smoke, air pollution, and asbestos.
5. Radiological diseases: These are caused by exposure to ionizing radiation and can include conditions such as radiographic breast cancer and lung cancer.
6. Vascular diseases: These are caused by problems with the blood vessels in the lungs and can include conditions such as pulmonary embolism and pulmonary hypertension.
7. Tumors: These can be benign or malignant and can include conditions such as lung metastases and lung cancer.
8. Trauma: This can include injuries to the chest or lungs caused by accidents or other forms of trauma.
9. Congenital diseases: These are present at birth and can include conditions such as bronchopulmonary foregut malformations and congenital cystic adenomatoid malformation.
Each type of lung disease has its own set of symptoms, diagnosis, and treatment options. It is important to seek medical attention if you experience any persistent or severe respiratory symptoms, as early diagnosis and treatment can improve outcomes and quality of life.
There are several types of colonic neoplasms, including:
1. Adenomas: These are benign growths that are usually precursors to colorectal cancer.
2. Carcinomas: These are malignant tumors that arise from the epithelial lining of the colon.
3. Sarcomas: These are rare malignant tumors that arise from the connective tissue of the colon.
4. Lymphomas: These are cancers of the immune system that can affect the colon.
Colonic neoplasms can cause a variety of symptoms, including bleeding, abdominal pain, and changes in bowel habits. They are often diagnosed through a combination of medical imaging tests (such as colonoscopy or CT scan) and biopsy. Treatment for colonic neoplasms depends on the type and stage of the tumor, and may include surgery, chemotherapy, and/or radiation therapy.
Overall, colonic neoplasms are a common condition that can have serious consequences if left untreated. It is important for individuals to be aware of their risk factors and to undergo regular screening for colon cancer to help detect and treat any abnormal growths or tumors in the colon.
A type of typhus fever that is caused by a bacterial infection and transmitted to humans through the bites of infected fleas. The disease is typically found in rural areas where there are poor living conditions and inadequate sanitation, and it is most commonly seen in parts of Africa and Asia.
Symptoms of endemic typhus fever include high fever, headache, muscle aches, and a rash that may appear on the abdomen or palms of the hands. In severe cases, the disease can lead to complications such as kidney failure, pneumonia, and death.
Diagnosis is typically made through physical examination and laboratory tests, and treatment usually involves antibiotics and supportive care to manage symptoms. Prevention measures include controlling flea populations on animals and in living areas, and improving sanitation and living conditions.
Previous articleTyphus, Epidemic Louse-Borne
Next articleTyphoid Fever
The term "Sarcoma 180" was coined by a German surgeon named Otto Kunkel in the early 20th century. He described this type of cancer as a highly malignant tumor that grows slowly but is resistant to treatment with surgery, radiation therapy, and chemotherapy.
The exact cause of Sarcoma 180 is not known, but it is believed to be linked to genetic mutations and exposure to certain chemicals or radiation. The disease typically affects middle-aged adults and is more common in men than women.
The symptoms of Sarcoma 180 can vary depending on the location of the tumor, but they may include pain, swelling, redness, and limited mobility in the affected area. If left untreated, the cancer can spread to other parts of the body and be fatal.
Treatment for Sarcoma 180 usually involves a combination of surgery, radiation therapy, and chemotherapy. In some cases, amputation of the affected limb may be necessary. The prognosis for this disease is generally poor, with a five-year survival rate of less than 50%.
In summary, Sarcoma 180 is a rare and aggressive form of cancer that affects connective tissue and has a poor prognosis. It is important for medical professionals to be aware of this condition and its symptoms in order to provide proper diagnosis and treatment.
There are several types of drug overdoses, including:
1. Opioid overdose: This is the most common type of drug overdose and is caused by taking too much of an opioid medication or street drug like heroin.
2. Stimulant overdose: This occurs when someone takes too much of a stimulant drug like cocaine or amphetamines.
3. Depressant overdose: This is caused by taking too much of a depressant drug like alcohol, benzodiazepines, or barbiturates.
4. Hallucinogenic overdose: This happens when someone takes too much of a hallucinogenic drug like LSD or psilocybin mushrooms.
The symptoms of a drug overdose can vary depending on the type of drug taken, but common signs include:
1. Confusion and disorientation
2. Slurred speech and difficulty speaking
3. Dizziness and loss of balance
4. Nausea and vomiting
5. Slow or irregular breathing
6. Seizures or convulsions
7. Cold, clammy skin
8. Blue lips and fingernails
9. Coma or unresponsiveness
10. Death
If you suspect someone has overdosed on drugs, it is essential to seek medical attention immediately. Call emergency services or bring the person to the nearest hospital.
Treatment for drug overdoses usually involves supportive care, such as oxygen therapy, fluids, and medication to manage symptoms. In severe cases, a patient may need to be placed on life support or receive other intensive treatments.
Preventing drug overdoses is crucial, and this can be achieved by avoiding the use of drugs altogether, using drugs only as directed by a medical professional, and having access to naloxone, a medication that can reverse the effects of an opioid overdose.
In conclusion, drug overdoses are a significant public health issue that can have severe consequences, including death. It is important to be aware of the signs and symptoms of drug overdoses and seek medical attention immediately if you suspect someone has overdosed. Additionally, prevention measures such as avoiding drug use and having access to naloxone can help reduce the risk of overdose.
There are several types of melanoma, including:
1. Superficial spreading melanoma: This is the most common type of melanoma, accounting for about 70% of cases. It usually appears as a flat or slightly raised discolored patch on the skin.
2. Nodular melanoma: This type of melanoma is more aggressive and accounts for about 15% of cases. It typically appears as a raised bump on the skin, often with a darker color.
3. Acral lentiginous melanoma: This type of melanoma affects the palms of the hands, soles of the feet, or nail beds and accounts for about 5% of cases.
4. Lentigo maligna melanoma: This type of melanoma usually affects the face and is more common in older adults.
The risk factors for developing melanoma include:
1. Ultraviolet (UV) radiation exposure from the sun or tanning beds
2. Fair skin, light hair, and light eyes
3. A history of sunburns
4. Weakened immune system
5. Family history of melanoma
The symptoms of melanoma can vary depending on the type and location of the cancer. Common symptoms include:
1. Changes in the size, shape, or color of a mole
2. A new mole or growth on the skin
3. A spot or sore that bleeds or crusts over
4. Itching or pain on the skin
5. Redness or swelling around a mole
If melanoma is suspected, a biopsy will be performed to confirm the diagnosis. Treatment options for melanoma depend on the stage and location of the cancer and may include surgery, chemotherapy, radiation therapy, or a combination of these. Early detection and treatment are key to successful outcomes in melanoma cases.
In conclusion, melanoma is a type of skin cancer that can be deadly if not detected early. It is important to practice sun safety, perform regular self-exams, and seek medical attention if any suspicious changes are noticed on the skin. By being aware of the risk factors, symptoms, and treatment options for melanoma, individuals can take steps to protect themselves from this potentially deadly disease.
The most common form of xanthomatosis is called familial hypercholesterolemia, which is caused by a deficiency of low-density lipoprotein (LDL) receptors in the body. This results in high levels of LDL cholesterol in the blood, which can lead to the accumulation of cholesterol and other lipids in the skin, eyes, and other tissues.
Other forms of xanthomatosis include:
* Familial apo A-1 deficiency: This is a rare disorder caused by a deficiency of apolipoprotein A-1 (apoA-1), a protein that plays a critical role in the transportation of triglycerides and cholesterol in the blood.
* familial hyperlipidemia: This is a group of rare genetic disorders that are characterized by high levels of lipids in the blood, including cholesterol and triglycerides.
* Chylomicronemia: This is a rare disorder caused by a deficiency of lipoprotein lipase, an enzyme that breaks down triglycerides in the blood.
The symptoms of xanthomatosis vary depending on the specific form of the condition and the organs affected. They may include:
* Yellowish deposits (xanthomas) on the skin, particularly on the elbows, knees, and buttocks
* Deposits in the eyes (corneal arcus)
* Fatty liver disease
* High levels of cholesterol and triglycerides in the blood
* Abdominal pain
* Weight loss
Treatment for xanthomatosis typically involves managing the underlying genetic disorder, which may involve dietary changes, medication, or other therapies. In some cases, surgery may be necessary to remove affected tissue.
In summary, xanthomatosis is a group of rare genetic disorders that are characterized by deposits of lipids in the skin and other organs. The symptoms and treatment vary depending on the specific form of the condition.
Symptoms of pheochromocytoma can include:
* Rapid heartbeat
* High blood pressure
* Sweating
* Weight loss
* Fatigue
* Headaches
* Nausea and vomiting
If left untreated, pheochromocytoma can lead to complications such as heart failure, stroke, and even death. Therefore, it is important that individuals who experience any of the above symptoms seek medical attention as soon as possible.
Treatment options for pheochromocytoma may include surgery to remove the tumor, medication to manage symptoms, and in some cases, radiation therapy. In rare cases, the tumor may recur after treatment, so regular monitoring is necessary to ensure that any new symptoms are detected early on.
Overall, while pheochromocytoma is a rare and potentially life-threatening condition, prompt medical attention and appropriate treatment can help manage symptoms and prevent complications.
Example sentence: The patient was diagnosed with experimental sarcoma and underwent a novel chemotherapy regimen that included a targeted therapy drug.
There are several types of diabetes mellitus, including:
1. Type 1 DM: This is an autoimmune condition in which the body's immune system attacks and destroys the cells in the pancreas that produce insulin, resulting in a complete deficiency of insulin production. It typically develops in childhood or adolescence, and patients with this condition require lifelong insulin therapy.
2. Type 2 DM: This is the most common form of diabetes, accounting for around 90% of all cases. It is caused by a combination of insulin resistance (where the body's cells do not respond properly to insulin) and impaired insulin secretion. It is often associated with obesity, physical inactivity, and a diet high in sugar and unhealthy fats.
3. Gestational DM: This type of diabetes develops during pregnancy, usually in the second or third trimester. Hormonal changes and insulin resistance can cause blood sugar levels to rise, putting both the mother and baby at risk.
4. LADA (Latent Autoimmune Diabetes in Adults): This is a form of type 1 DM that develops in adults, typically after the age of 30. It shares features with both type 1 and type 2 DM.
5. MODY (Maturity-Onset Diabetes of the Young): This is a rare form of diabetes caused by genetic mutations that affect insulin production. It typically develops in young adulthood and can be managed with lifestyle changes and/or medication.
The symptoms of diabetes mellitus can vary depending on the severity of the condition, but may include:
1. Increased thirst and urination
2. Fatigue
3. Blurred vision
4. Cuts or bruises that are slow to heal
5. Tingling or numbness in hands and feet
6. Recurring skin, gum, or bladder infections
7. Flu-like symptoms such as weakness, dizziness, and stomach pain
8. Dark, velvety skin patches (acanthosis nigricans)
9. Yellowish color of the skin and eyes (jaundice)
10. Delayed healing of cuts and wounds
If left untreated, diabetes mellitus can lead to a range of complications, including:
1. Heart disease and stroke
2. Kidney damage and failure
3. Nerve damage (neuropathy)
4. Eye damage (retinopathy)
5. Foot damage (neuropathic ulcers)
6. Cognitive impairment and dementia
7. Increased risk of infections and other diseases, such as pneumonia, gum disease, and urinary tract infections.
It is important to note that not all individuals with diabetes will experience these complications, and that proper management of the condition can greatly reduce the risk of developing these complications.
Paper chromatography
History of chromatography
List of research methods in biology
Lateral flow test
Partition chromatography
Gerrit Friedrich Otto Toennies
Joan Mattingley
Phenolic acid
Diamidophosphate
Richard Willstätter
Alma Levant Hayden
Ribose-5-phosphate isomerase
High-performance liquid chromatography
Thearubigin
Epidemic dropsy
Edith Kroupa
Alejandro Zaffaroni
Δ7-Prednisolone
Thin-layer chromatography
5-Methylcytosine
Ninhydrin
Friedlieb Ferdinand Runge
Johanna Budwig
Indospicine
Erwin Chargaff
Forestal
Adrenochrome
Malolactic fermentation
Chromatography
Chloroplast
Metabolism
Universality (dynamical systems)
Hans Runemark
Philippine Nuclear Research Institute
Jean Fréchet
Fritted glass
Journal of Chromatography A
Digital rights management
Polystyrene
Journal of Chromatographic Science
Viking lander biological experiments
Biogenic substance
Yohimbine
Metformin
Palace Museum
Eye dropper
Amorphous poly alpha olefin
Glossary of dyeing terms
Epibatidine
Spectrophotometry
Centre for Applied Genomics
Archer Martin
Ambient ionization
Ayya Nadar Janaki Ammal College
1903 in science
Molybdenum blue
Arnold Demain
Group 5 element
Polyethylene glycol
Forensic chemistry
Chromatography Paper, Roll | Flinn Scientific
Paper Chromatography of Phosphoric Esters - Wikidata
Chromatography Blotting Paper - 2388-2030 - Grade 238, 20cm x 30cm: Lab Filtration Papers from Ahlstrom
Sci.chem FAQ - Part 1 of 7
Ask an Expert: Life, Earth, and Social Sciences
NIOSHTIC-2 Search Results - Full View
The EPA National Library Catalog | EPA National Library Network | US EPA
Build your own Apologia Advanced Chemistry lab kit - Nature's Workshop Plus
SCIENTIFIC ABSTRACT KAVINOV, I.F. (MOSKVA) - KAVRAKIROV, B. | CIA FOIA (foia.cia.gov)
Identification of Synthetic Food Colours in Selected Confectioneries and Beverages in Jaffna District, Sri Lanka
Ink Chromatography Kit | Boreal Science
Successful combined contact for three schools in south Italy, with Paolo Nespoli IZØJPA
Graham Professional Exam Table Roll Paper Crepe; 18 x 125 in.:First Aid
| Fisher Scientific
CG-8282 - DISHES, DRYING, PYREX®- Chemglass Life Sciences
Adeno-Associated Virus 2 and Human Adenovirus F41 in Wastewater during Outbreak of Severe Acute Hepatitis in Children, Ireland ...
About the Analytical Science Community
WHO EMRO | Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011 |...
Qualitative Cobalt test paper for Cobalt:25 mg/L Co²⁺, MN | MACHEREY-NAGEL
The Role of Martin and Synge in the Birth of Modern Chromatography Chromatography Today
JCI Insight -
DIO3 protects against thyrotoxicosis-derived cranio-encephalic and cardiac congenital abnormalities
Draw structures of alkenes (Full structural formula) [Online Lesson] - O Level Secondary Chemistry Tuition
Biochemistry Quotes - 49 quotes on Biochemistry Science Quotes - Dictionary of Science Quotations and Scientist Quotes
ISOGG 2019-2020 Y-DNA Papers Cited
PRIME PubMed | Capillary electrokinetic chromatography of insulin and related synthetic analogues
CCCC 1950, Volume 15, Issue 0, Abstracts pp. 937-945, Articles by the same authors | Collection of Czechoslovak Chemical...
Evolution and Innovations of the National Neonatal and High Risk Screening Program in Costa Rica
Uncategorized - Page 2 - AFNS Stores
Quantitative determination of phosphatidylethanol in dried blood spots for monitoring alcohol abstinence | Nature Protocols
Tandem mass spectro2
- Extraction of the analytes from DBS filter paper cards is performed using an organic extraction, followed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). For accurate and reliable measurement of PEth, the two most abundant analogs, PEth 16:0/18:1 and PEth 16:0/18:2, are quantified. (nature.com)
- The method uses 200 microliters of urine and is based on 2D-on-line ion chromatography coupled with tandem mass spectrometry (IC- MS/MS) and isotope dilution quantification (Schutze et. (cdc.gov)
Partition chromatography2
- A study making extensive use of techniques based on paper partition chromatography. (wikidata.org)
- The new form of chromatography that they described became known as ' partition chromatography ' due to the way that the sample ' partitioned ' itself between the two liquid phases. (chromatographytoday.com)
Electrophoresis3
- This paper can be used in electrophoresis applications. (flinnsci.ca)
- They can be used with paper or gel electrophoresis or paper chromatography. (chemglass.com)
- Within the work presented in this paper, capillary zone electrophoresis (CZE), micellar electrokinetic chromatography (MEKC) with sodium dodecylsulphate (SDS) as micelle-forming agent, and microemulsion electrokinetic chromatography (MEEKC) with microemulsions consisting of SDS, n-octane and 1-butanol were investigated for the separation of human insulin and five synthetic analogues. (unboundmedicine.com)
Mass spectroscopy2
- The principal method used for the detection of diazinon or its metabolites in biological samples is gas chromatography (GC) using a flame photometric detector (FPD), a mass spectroscopy detector (MS), an electron capture detector (ECD), or a flame ionization detector (FID). (cdc.gov)
- The paste was analyzed by gas chromatography/mass spectroscopy (GC/MS) and found to contain butanoic acid, butyl ester, N-butyl ether, acetic acid, toluene, di-tert-butyl peroxide, 1-butanol, acetic acid ethenyl ester, isopropyl alcohol, and ethylene dioxide. (cdc.gov)
HPLC1
- 1 extraction was carried out using immunoaffinity column, separated by reversed-phase (C-18) high performance liquid chromatography (HPLC) , and quantified by fluorescence detector. (bvsalud.org)
19952
- This paper reports data since the programme started in January 1995 up to December 2011 on the incidence of screened disorders and the molecular basis of positive screened cases. (who.int)
- L'article présente les données collectées, depuis le commencement du programme en janvier 1995 jusqu'en décembre 2011, sur l'incidence des troubles dépistés ainsi que la base moléculaire des cas positifs dépistés. (who.int)
Sodium1
- Concentration and 1987 greater purification by sweep co-distillation omentum) and Florisil/anhydrous sodium sulfate column chromatography. (cdc.gov)
Detection1
- As a substrate material, paper (and related porous hydrophilic materials) has many unique advantages over traditional device materials including power-free fluid transport via capillary action, a high surface area to volume ratio that improves detection limits for colorimetric methods, and the ability to store reagents in active form within the fiber network. (cdc.gov)
Analytical4
- Paper has been used as a substrate material in analytical testing for centuries, with scientific reports dating back to the early 1800s with litmus paper. (cdc.gov)
- reported the first microfluidic paper-based analytical device (iPAD) for chemical analysis. (cdc.gov)
- We also limited our search criteria and resulting discussion to papers describing analytical measurements. (cdc.gov)
- Chromatography is a standard analytical tool for today's chemists and biochemists - found in most laboratories it is the key technique for separating compounds into their components. (chromatographytoday.com)
Grade1
- Chromatography paper is a fine grade of paper made from cotton cellulose. (flinnsci.ca)
Strips2
- The paper is available in three forms: roll, sheet and strips. (flinnsci.ca)
- Lab materials include Chromatography vials with caps, Chromatography paper strips, 4 different pens with water soluable ink, Rulers, Microfuge tubes, and Pipets. (boreal.com)
Scientific1
- is an author on scientific papers, white papers, chromatography articles and a degree module and has co-authored a book with the RSC as a practical reference to Gas Chromatography-Mass Spectrometry, for analysts at all experience levels. (rsc.org)
Colors1
- Kids learn the colors of the rainbow along with chromatography as they watch marker streaks climb up and meet across a wet paper towel. (weareteachers.com)
Data1
- One example of this is a CDMS, or chromatography data management system. (cdc.gov)
Liquid4
- Archer J.P. Martin and Richard L.M. Synge worked together at the Wool Industries Research Association in Leeds and in 1941 they published a paper entitled ' A New Form of Chromatogram Employing Two Liquid Phases ' in the Biochemical Journal. (chromatographytoday.com)
- This paper reports the incidence of sickle cell diseases, other haemoglobinopathies and haemoglobinopathy carriers over a 12-month period using high performance liquid chromatography as a primary screening method. (who.int)
- DNA probes and mycolic acids high-pressure liquid chromatography performed on a culture from a clinical specimen) are acceptable under this criterion. (cdc.gov)
- Sera and urine specimens, green mussel and seawater samples were tested for Saxitoxin levels using High Power Liquid Chromatography. (who.int)
Techniques2
- In this lab activity, students will master the techniques of paper chromatography. (boreal.com)
- Many of the advances in chemistry and biology are based on new techniques being discovered in chromatography - leading to new molecules being discovered. (chromatographytoday.com)
Column3
- How Do You Prepare Column Chromatography? (chromatographytoday.com)
- How Does Column Diameter Affect Column Chromatography? (chromatographytoday.com)
- In the first part of the paper, Martin and Synge for the first time ever, presented a theory of chromatography that attempted to explain the concentration of the solute at any point in the column and also how the resolution of the column was affected by various factors including the column's length. (chromatographytoday.com)
Separate1
- Using paper chromatography, students will separate the inks of several water soluble pens, calculate the relative rate of flow for each color dye on the chromatogram, and identify a type of pen based upon the quantitative measurements obtained. (boreal.com)
Applications3
- This medium thick paper is recommended for general chromatography applications. (labfiltrationpapers.com)
- As a result of these benefits, paper has been used in applications ranging from spot tests for metals and paper chromatography to lateral flow immunoassays. (cdc.gov)
- This simple yet elegant development led many to realize paper as a substrate material for applications where low-cost and portability are critically important. (cdc.gov)
Programme1
- RÉSUMÉ Le programme national de dépistage néonatal aux Émirats arabes unis couvre actuellement 16 maladies ou troubles : l'hyperthyroïdie congénitale, la drépanocytose, l'hyperplasie congénitale des surrénales, le déficit en biotinidase ainsi que 12 troubles des acides aminés, organiques et gras. (who.int)
Article1
- There are several factors that affect HETP - for an introduction to HETP see this article on the Chromatography Today website - and the work by Martin and Synge gave an HETP of 0.002cm, previous separations with columns had only achieved an HETP of 1.0cm. (chromatographytoday.com)
Field3
- During this time over 1 000 articles have been published in the field, making a full comprehensive review citing all papers impossible. (cdc.gov)
- As a result, we seek to highlight the papers we find to be most impactful for the field. (cdc.gov)
- The paper written by Martin and Synge was important because it laid the foundations of all the future work in the field of chromatography. (chromatographytoday.com)
Activities1
- Thus, this paper "reviews" technical assistance activities related to drug supply in light of the additional responsibilities assumed by the Organization with the establishment of the Strategic Fund. (who.int)
Leaves1
- Chromatography was invented by Mikhail Tsvet in the 1900s - he separated the different pigments found in green leaves using tube packed with a solid material. (chromatographytoday.com)
Filter1
- A package of 10, 9cm diameter filter papers. (workshopplus.com)